Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: The results of a parent survey

Autism

Volumn 12, Issue 3, 2008, Pages 293-307

  Schultz, Stephen T ^a,b,c   Klonoff Cohen, Hillary S ^a   Wingard, Deborah L ^a   Akshoomoff, Natacha A ^a   Macera, Caroline A ^b   Ming, Ji ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Acetaminophen; Autism; Paracetamol; Vaccination

Indexed keywords

IBUPROFEN; MEASLES MUMPS RUBELLA VACCINE; PARACETAMOL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DIARRHEA; DRUG ERUPTION; DRUG FEVER; ETHNICITY; FEMALE; HEALTH SURVEY; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; ONLINE SYSTEM; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; REMISSION; SEIZURE; SEX DIFFERENCE; SIDE EFFECT;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; DRUG INTERACTIONS; FEMALE; HEALTH SURVEYS; HUMANS; IBUPROFEN; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; RISK;

EID: 41949092859     PISSN: 13623613     EISSN: 14617005     Source Type: Journal    
DOI: 10.1177/1362361307089518     Document Type: Article

References (31)

1. Alberti, A., Pirrone, P., Elia, M., Waring, R.H. & Romano, C. (1999) 'Sulphation Deficit in "Low-Functioning" Autistic Children: A Pilot Study', Biological Psychiatry 46: 420-4.
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). Washington, DC: APA.
3. CDC (2006) Epidemiology and Prevention of Vaccine-Preventible Diseases, 9th edn. Atlanta, GA: Centers for Disease Control and Prevention.
4. Chen, W., Landau, S., Sham, P. & Fombonne, E. (2004) 'No Evidence for Links between Autism, MMR and Measles Virus', Psychological Medicine 34: 543-53.
5. Courchesne E., Carper R. & Akshoomoff, N. (2003) 'Evidence of Brain Overgrowth in the First Year of Life in Autism', Journal of the American Medical Association 290 (3): 337-44.
6. Dales, L., Hammer, S.J. & Smith, N.J. (2001) 'Time Trends in Autism and in MMR Immunization Coverage in California', Journal of the American Medical Association 285 (9): 1183-5.
7. Fombonne, E. (1999) 'The Epidemiology of Autistic Disorder: A Review', Psychological Medicine 29 (4): 769-86.
8. Fombonne, E. & Chakrabarti, S. (2001) 'No Evidence for a New Variant of Measles-Mumps-Rubella-Induced Autism', Pediatrics 108: E58.
9. Furlano, R.I., Anthony, A., Day, R., Brown, A., Mcgarvey, L., Thomson, M.A., Davies, S.E., Berelowitz, M., Forbes, A., Wakefield, A.J., Walker-Smith, J. A. & Murch, S.H. (2001) 'Colonic CD8 and Gamma Delta T-Cell Infiltration with Epithelial Damage in Children with Autism', Journal of Pediatrics 138 (3): 366-72.
10. Hertz-Picciotto, I., Croen, L.A., Hansen, R., Jones, C.R., Van De Water, J. & Pessah, I.N. (2006) 'The CHARGE Study: An Epidemiologic Investigation of Genetic and Environmental Factors Contributing to Autism', Environmental Health Perspectives 114 (7): 1119-25.
11. Horton, R. (2004) 'The Lessons of MMR', Lancet 363: 747-9.
12. Institute Of Medicine (2001) Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. Washington, DC: National Academy Press.
13. Lawler, C.P., Croen, L.A., Grether, J.K. & Van DE Water, J. (2004) 'Identifying Environmental Contributions to Autism: Provocative Clues and False Leads', Mental Retardation and Developmental Disabilities Research Reviews 10 (4): 292-302.
14. Lord, C., Shulman, C. & Dilavore, P. (2004) 'Regression and Word Loss in Autistic Spectrum Disorders', Journal of Child Psychology and Psychiatry, and Allied Disciplines 45 (5): 936-55.
15. Madsen, K.M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J. & Melbye, M. (2002) 'A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism', New England Journal of Medicine 347 (19): 1477-82.
16. Muhle, R., Trentacoste S.V. & Rapin, I. (2004) 'The Genetics of Autism', Pediatrics 113: E472-e486.
17. Murch, S.H., Anthony, A., Casson, D.H., Malik, M., Berelowitz, M., Dhillon, A.P., Thomson, M.A., Valentine, A., Davies, S.E. & Walker-Smith J.A. (2004) 'Retraction of an Interpretation', Lancet 363:750.
18. Peltola, H., Patja, A., Leinikki, P., Valle, M., Davidkin, I. & Paunio, M. (1998) 'No Evidence for Measles, Mumps, and Rubella Vaccine-Associated Inflammatory Bowel Disease or Autism in a 14-Year Prospective Study', Lancet 351: 1327-8.
19. Schultz, S.T., Wingard, D.L., Klonoff-Cohen, H.S., Akshoomoff, N.A., Macera, C.A. & Ji, M. (submitted) 'National Acetaminophen Sales and Autistic Disorder in California: An Ecological Association '.
20. Singh V. K. & Jensen, R.L. (2003) 'Elevated Levels of Measles Antibodies in Children with Autism', Pediatric Neurology 28 (4): 292-4.
21. Singh, V.K., Lin, S.X., Newell, E. & Nelson, C. (2002) 'Abnormal Measles-Mumps-Rubella Antibodies and CNS Autoimmunity in Children with Autism', Journal of Biomedical Science 9 (4): 359-64.
22. Taylor, B., Miller, E., Farrington, C.P., Petropoulos, M.C., Favot-Mayaud, I., Li, J. & Waight, P.A. (1999) 'Autism and Measles, Mumps, and Rubella Vaccine: No Epidemiological Evidence for a Causal Association', Lancet 353 (9169): 2026-9.
23. Taylor, B., Miller, E., Lingam, R., Andrews, N., Simmons, A. & Stowe, J. (2002) 'Measles, Mumps, and Rubella Vaccination and Bowel Problems or Developmental Regression in Children with Autism: Population Study', British Medical Journal 324 (7334): 393-6.
24. Torrente, F., Ashwood, P., Day, R., Machado, N., Furlano, R.I., Anthony, A., Davies, S.E., Wakefield, A.J., Thomson, M.A., Walker-Smith, J.A. & Murch, S.H. (2002) 'Small Intestinal Enteropathy with Epithelial IgG and Complement Deposition in Children with Regressive Autism', Molecular Psychiatry 7 (4): 375-82, 334.
25. Tucker, J. (2003) 'Toxicity, Acetaminophen', retrieved November 7, 2005 from http://www.emedicine.com/ped/topic7.htm
26. Uhlmann, V., Martin, C.M., Sheils, O., Pilkington, L., Silva, I., Killalea, A., Murch, S.B., Walker-Smith, J., Thomson, M., Wakefield, A.J. & O' Leary, J.J. (2002) 'Potential Viral Pathogenic Mechanism for New Variant Inflammatory Bowel Disease', Molecular Pathology 55 (2): 84-90.
27. Wakefield, A.J., Murch, S.H., Anthony, A., Linnell, J., Casson, D.M., Malik, M., Derelowitz, M., Dhillon, A.P., Thomson, M.A., Harvey, P., Valentine, A., Davies, S.E. & Walker-Smith, J.A. (1998) 'Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis, and Pervasive Developmental Disorder in Children', Lancet 351: 637-41.
28. Wakefield, A.J., Anthony, A., Murch, S.H., Thomson, M., Montgomery, S.M., Davies, S., O'Leary, J.J., Berelowitz, M. & Walker-Smith, J.A. (2000) 'Enterocolitis in Children with Developmental Disorders', The American Journal of Gastroenterology 95 (9): 2285-95.
29. Waring, R.H. & Harris, R.M. (2005), 'Sulphation and Gut Function in Autistic Spectrum Disorders: The Potential Role of Nutrition', The Nutrition Practitioner 6 (3): 1-10.
30. Waring, R.H. & Klovrza, J. (2000) 'Sulphur Metabolism in Autism', Journal of Nutritional and Environmental Medicine 10: 25-32.
31. Wilkinson, L.J. & Waring, R.H. (2002) 'Cysteine Dioxygenase: Modulation of Expression in Human Cell Lines by Cytokines and Control of Sulphate Production', Toxicology in vitro 16: 481-3.